New Diagnostic Aids for Melanoma

Dermatologic Clinics

Volumn 30, Issue 3, 2012, Pages 535-545

  Ferris, Laura Korb ^a   Harris, Ryan J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Automated diagnosis; Biopsy; Imaging; Melanoma detection; Technology

Indexed keywords

IPILIMUMAB;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; COMPETENCE; CONFOCAL LASER MICROSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ELASTOGRAPHY; EPILUMINESCENCE MICROSCOPY; HEALTH CARE COST; HUMAN; IMAGE ANALYSIS; INSURANCE; MELAFIND; MELANOMA; MORBIDITY; MORTALITY; NON INVASIVE PROCEDURE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; SENSITIVITY AND SPECIFICITY; SIASCOPY;

DIAGNOSTIC EQUIPMENT; EARLY DETECTION OF CANCER; HUMANS; MELANOMA; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 84863879196     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2012.04.012     Document Type: Review

References (63)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 6(1):10-29.
2. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
3. Balch C.M., Gershenwald J.E., Soong S.J., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
4. Alexandrescu D.T. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatol Online J 2009, 15:1.
5. Friedman R.J., Gutkowicz-Krusin D., Farber M.J., et al. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol 2008, 144:476-482.
6. Carli P., Nardini P., Crocetti E., et al. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study. Melanoma Res 2004, 14:403-407.
7. Wilson R.L., Yentzer B.A., Isom S.P., et al. How good are US dermatologists at discriminating skin cancers? A number-needed-to-treat analysis. J Dermatolog Treat 2012, 23(1):65-69.
8. Cohen M.H., Cohen B.J., Shotkin J.D., et al. Surgical prophylaxis of malignant melanoma. Ann Surg 1991, 213:308-314.
9. Brady M.S., Oliveria S.A., Christos P.J., et al. Patterns of detection in patients with cutaneous melanoma. Cancer 2000, 89:342-347.
10. Epstein D.S., Lange J.R., Gruber S.B., et al. Is physician detection associated with thinner melanomas?. JAMA 1999, 281:640-643.
11. Kantor J., Kantor D.E. Routine dermatologist-performed full-body skin examination and early melanoma detection. Arch Dermatol 2009, 145:873-876.
12. Abbasi N.R., Shaw H.M., Rigel D.S., et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004, 292:2771-2776.
13. Rigel D.S., Friedman R.J., Kopf A.W., et al. ABCDE-an evolving concept in the early detection of melanoma. Arch Dermatol 2005, 141:1032-1034.
14. Berwick M., Begg C.B., Fine J.A., et al. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996, 88:17-23.
15. Carli P., De Giorgi V., Palli D., et al. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 2003, 139:607-612.
16. Pollitt R.A., Geller A.C., Brooks D.R., et al. Efficacy of skin self-examination practices for early melanoma detection. Cancer Epidemiol Biomarkers Prev 2009, 18:3018-3023.
17. Trolle L., Henrik-Nielsen R., Gniadecki R. Ability to self-detect malignant melanoma decreases with age. Clin Exp Dermatol 2011, 36:499-501.
18. Fisher N.M., Schaffer J.V., Berwick M., et al. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol 2005, 53:393-406.
19. de Troya-Martin M., Blazquez-Sanchez N., Fernandez-Canedo I., et al. Actas Dermosifiliogr 2008, 99:44-53. [in Spanish].
20. Carli P., de Giorgi V., Chiarugi A., et al. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. J Am Acad Dermatol 2004, 50:683-689.
21. Carli P., De Giorgi V., Crocetti E., et al. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001. Br J Dermatol 2004, 150:687-692.
22. Piccolo D., Ferrari A., Peris K., et al. Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer-aided diagnosis of 341 pigmented skin lesions: a comparative study. Br J Dermatol 2002, 147:481-486.
23. Noor O., Nanda A., Rao B.K. A dermoscopy survey to assess who is using it and why it is or is not being used. Int J Dermatol 2009, 48:951-952.
24. Haenssle H.A., Krueger U., Vente C., et al. Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. J Invest Dermatol 2006, 126:980-985.
25. Menzies S.W., Emery J., Staples M., et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol 2009, 161:1270-1277.
26. Risser J., Pressley Z., Veledar E., et al. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. J Am Acad Dermatol 2007, 57:428-434.
27. Banky J.P., Kelly J.W., English D.R., et al. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005, 141:998-1006.
28. Meyer L.E., Otberg N., Sterry W., et al. In vivo confocal scanning laser microscopy: comparison of the reflectance and fluorescence mode by imaging human skin. J Biomed Opt 2006, 11:044012.
29. Busam K.J., Hester K., Charles C., et al. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy. Arch Dermatol 2001, 137:923-929.
30. Ono I., Sakemoto A., Ogino J., et al. The real-time, three-dimensional analyses of benign and malignant skin tumors by confocal laser scanning microscopy. J Dermatol Sci 2006, 43:135-141.
31. Rajadhyaksha M., Gonzalez S., Zavislan J.M., et al. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J Invest Dermatol 1999, 113:293-303.
32. Gerger A., Koller S., Kern T., et al. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors. J Invest Dermatol 2005, 124:493-498.
33. Gerger A., Hofmann-Wellenhof R., Langsenlehner U., et al. In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images. Br J Dermatol 2008, 158:329-333.
34. Langley R.G., Walsh N., Sutherland A.E., et al. The diagnostic accuracy of in vivo confocal scanning laser microscopy compared to dermoscopy of benign and malignant melanocytic lesions: a prospective study. Dermatology 2007, 215:365-372.
35. Gerger A., Wiltgen M., Langsenlehner U., et al. Diagnostic image analysis of malignant melanoma in in vivo confocal laser-scanning microscopy: a preliminary study. Skin Res Technol 2008, 14:359-363.
36. Koller S., Wiltgen M., Ahlgrimm-Siess V., et al. In vivo reflectance confocal microscopy: automated diagnostic image analysis of melanocytic skin tumours. J Eur Acad Dermatol Venereol 2011, 25:554-558.
37. Wiltgen M., Bloice M., Koller S., et al. Computer-aided diagnosis of melanocytic skin tumors by use of confocal laser scanning microscopy images. Anal Quant Cytol Histol 2011, 33:85-100.
38. Moncrieff M., Cotton S., Claridge E., et al. Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol 2002, 146:448-457.
39. Haniffa M.A., Lloyd J.J., Lawrence C.M. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic. Br J Dermatol 2007, 156:1350-1352.
40. Emery J.D., Hunter J., Hall P.N., et al. Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm. BMC Dermatol 2010, 10:9.
41. Gutkowicz-Krusin D., Elbaum M., Jacobs A., et al. Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind(TM) multispectral digital dermoscope. Melanoma Res 2000, 10:563-570.
42. Monheit G., Cognetta A.B., Ferris L., et al. The performance of MelaFind: a prospective multicenter study. Arch Dermatol 2011, 147:188-194.
43. Kivela T. Diagnosis of uveal melanoma. Dev Ophthalmol 2012, 49:1-15.
44. Vogt M., Knuttel A., Hoffmann K., et al. Comparison of high frequency ultrasound and optical coherence tomography as modalities for high resolution and non invasive skin imaging. Biomed Tech 2003, 48:116-121.
45. de Giorgi V., Stante M., Massi D., et al. Possible histopathologic correlates of dermoscopic features in pigmented melanocytic lesions identified by means of optical coherence tomography. Exp Dermatol 2005, 14:56-59.
46. Welzel J. Optical coherence tomography in dermatology: a review. Skin Res Technol 2001, 7:1-9.
47. Rallan D., Bush N.L., Bamber J.C., et al. Quantitative discrimination of pigmented lesions using three-dimensional high-resolution ultrasound reflex transmission imaging. J Invest Dermatol 2007, 127:189-195.
48. Wachsman W., Morhenn V., Palmer T., et al. Noninvasive genomic detection of melanoma. Br J Dermatol 2011, 164:797-806.
49. Cone C.D. The role of the surface electrical transmembrane potential in normal and malignant mitogenesis. Ann N Y Acad Sci 1974, 238:420-435.
50. Han A., Yang L., Frazier A.B. Quantification of the heterogeneity in breast cancer cell lines using whole-cell impedance spectroscopy. Clin Cancer Res 2007, 13:139-143.
51. Alqabandi J.A., Abdel-Motal U.M., Youcef-Toumi K. Extracting cancer cell line electrochemical parameters at the single cell level using a microfabricated device. Biotechnol J 2009, 4:216-223.
52. Aberg P., Birgersson U., Elsner P., et al. Electrical impedance spectroscopy and the diagnostic accuracy for malignant melanoma. Exp Dermatol 2011, 20:648-652.
53. Har-Shai Y., Glickman Y.A., Siller G., et al. Electrical impedance scanning for melanoma diagnosis: a validation study. Plast Reconstr Surg 2005, 116:782-790.
54. Astbury W.T., Street A X-ray studies of the structure of hair, wool, and related fibres. I. General. Trans R Soc Lond 1931, 230:75-101.
55. James V.J. Fiber diffraction of skin and nails provides an accurate diagnosis of malignancies. Int J Cancer 2009, 125:133-138.
56. Ophir J., Cespedes I., Ponnekanti H., et al. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 1991, 13:111-134.
57. Hinz T., Wenzel J., Schmid-Wendtner M.H. Real-time tissue elastography: a helpful tool in the diagnosis of cutaneous melanoma?. J Am Acad Dermatol 2011, 65:424-426.
58. Ginat D.T., Destounis S.V., Barr R.G., et al. US elastography of breast and prostate lesions. Radiographics 2009, 29:2007-2016.
59. Herman C., Cetingul M.P. Quantitative visualization and detection of skin cancer using dynamic thermal imaging. J Vis Exp 2011, (51). pii: 2679.
60. Ehmann R., Boedeker E., Friedrich U., et al. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J 2012, 39(3):669-676.
61. McCulloch M., Jezierski T., Broffman M., et al. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther 2006, 5:30-39.
62. Williams H., Pembroke A. Sniffer dogs in the melanoma clinic?. Lancet 1989, 1:734.
63. Church J., Williams H. Another sniffer dog for the clinic?. Lancet 2001, 358:930.